Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Exome sequencing reveals MCM8 mutation underlies ovarian failure and chromosomal instability
Saleh AlAsiri, … , Michael A. Trakselis, Aleksandar Rajkovic
Saleh AlAsiri, … , Michael A. Trakselis, Aleksandar Rajkovic
Published December 1, 2014
Citation Information: J Clin Invest. 2015;125(1):258-262. https://doi.org/10.1172/JCI78473.
View: Text | PDF
Brief Report Genetics

Exome sequencing reveals MCM8 mutation underlies ovarian failure and chromosomal instability

  • Text
  • PDF
Abstract

Premature ovarian failure (POF) is a genetically and phenotypically heterogeneous disorder that includes individuals with manifestations ranging from primary amenorrhea to loss of menstrual function prior to age 40. POF presents as hypergonadotropic hypogonadism and can be part of a syndrome or occur in isolation. Here, we studied 3 sisters with primary amenorrhea, hypothyroidism, and hypergonadotropic hypogonadism. The sisters were born to parents who are first cousins. SNP analysis and whole-exome sequencing revealed the presence of a pathogenic variant of the minichromosome maintenance 8 gene (MCM8, c.446C>G; p.P149R) located within a region of homozygosity that was present in the affected daughters but not in their unaffected sisters. Because MCM8 participates in homologous recombination and dsDNA break repair, we tested fibroblasts from the affected sisters for hypersensitivity to chromosomal breaks. Compared with fibroblasts from unaffected daughters, chromosomal break repair was deficient in fibroblasts from the affected individuals, likely due to inhibited recruitment of MCM8 p.P149R to sites of DNA damage. Our study identifies an autosomal recessive disorder caused by an MCM8 mutation that manifests with endocrine dysfunction and genomic instability.

Authors

Saleh AlAsiri, Sulman Basit, Michelle A. Wood-Trageser, Svetlana A. Yatsenko, Elizabeth P. Jeffries, Urvashi Surti, Deborah M. Ketterer, Sibtain Afzal, Khushnooda Ramzan, Muhammad Faiyaz-Ul Haque, Huaiyang Jiang, Michael A. Trakselis, Aleksandar Rajkovic

×

Figure 3

MCM8 mutation disrupts MCM8 foci formation and DNA binding.

Options: View larger image (or click on image) Download as PowerPoint
MCM8 mutation disrupts MCM8 foci formation and DNA binding.
(A) MCM8 c.4...
(A) MCM8 c.446C>G (p.P149R) mutation inhibits MCM8 foci formation at sites of DNA damage. HEK293T cells were transfected with wild-type MCM8-GFP (WT) or mutant MCM8-GFP (p.P149R; shown in green) and treated with 300 nM MMC for 6 hours. Nuclei were counterstained with DAPI (blue). Foci formed in 293T cells expressing wild-type MCM8, but not in cells expressing mutant MCM8. Four independent experiments for transfection of MCM8-GFP (WT vs. p.P149R) coupled with DNA damage were performed. Representative confocal images are shown. (B) Twenty representative cells per condition were quantified for the number of damage-induced nuclear foci. A 2-tailed t test (assuming unequal variance) revealed a statistically significant difference (***P < 0.001) between wild-type (14 ± 0.9 foci/cell) and c.446C>G-expressing (3.5 ± 0.2 foci/cell) cells. Error bars represent SEM. (C) MCM8 c.446C>G (p.P149R) inhibited DNA binding by EMSA. Wild-type MCM8 or mutant MCM8 (p.P149R) protein was bound to a random 46 nt ssDNA oligonucleotide. Gels were imaged, and quantification of the fraction of band shift was performed. Data were fit to a single-site binding model defined by ΔF[MCM8]/KD + [MCM8], where F is the fraction bound and KD is the dissociation constant. Mutant MCM8 (p.P149R, blue squares) showed a significant reduction in DNA binding affinity for ssDNA at each concentration when compared with that of wild-type MCM8 (WT, black circles). Each point is the average of 3 replicates. Error bars represent SD.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts